tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Stephan, 50 are a HOLD (43.1%), 65 are a BUY (56.03%), 1 are a SELL (0.86%).
Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 66.74% that have a potential upside of 15.71% achieved within 75 days.
Thomas Stephan’s has documented 235 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GKOS, Glaukos Corp.
Analyst best performing recommendations are on CLPT (CLEARPOINT NEURO).
The best stock recommendation documented was for RXST (RXSIGHT) at 8/10/2026. The price target of $7 was fulfilled within 1 day with a profit of $0.43 (6.54%) receiving and performance score of 65.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2025
$247
$9.4 (3.96%)
$188
Buy Since 01-Aug-2024
$255
$17.4 (7.32%)
$215
Buy Since 04-Oct-2022
$251
$13.4 (5.64%)
$201
Buy Since 29-Sep-2025
$240
$2.4 (1.01%)
$195
Buy Since 26-Jun-2023
$225
$-12.6 (-5.30%)
$190
Which stock is Thomas Stephan most bullish on?
Which stock is Thomas Stephan most reserved on?
What Year was the first public recommendation made by Thomas Stephan?
